4.62 USD
↗ 0.02 (0.43%)AT CLOSE (11:59 AM EDT)
Edesa Biotech, Inc. Common Shares
EDSANASDAQ • USD
4.65
↗ 0.03 (0.63%)
POST MARKET (AS OF 07:38 PM EDT)
Post Market
AS OF 07:38 PM EDT
4.65
↗ 0.03 (0.63%)
Market: CLOSED
Shares of Edesa Biotech, Inc. Common Shares (EDSA) are trading at $4.62. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, EDSA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 28, 2026.
Open?$4.65
High?$4.93
Low?$4.50
Prev. Close?$4.60
Volume?70.7K
Avg. Volume?86.5K
VWAP?$4.60
Rel. Volume?0.82x
Bid / Ask
Bid?$4.50 × 100
Ask?$4.80 × 200
Spread?$0.30
Midpoint?$4.65
Valuation & Ratios
Market Cap?44.5M
Shares Out?9.6M
Float?3.6M
Float %?51.1%
P/E Ratio?N/A
P/B Ratio?5.06
EPS?-$1.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Employees
17
Market Cap
44.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2010-06-09
Address
100 SPY COURT
MARKHAM,
Phone: (905) 475-1234
MARKHAM,
Phone: (905) 475-1234
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?69
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.88Distress
Confidence?47%Low
Short InterestHigh
Short % of Float?5.81%Elevated
Short Interest?209.0K
Days to Cover?5.9
Free Float3.6M
Avg Daily Volume35.7K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.76Strong
Quick Ratio?2.76Strong
Cash Ratio?2.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.06FAIR▾
Peers100
S&P36
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-160.1%WEAK▾
S&P3
ROA?-110.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-8907623
Enterprise Value?$34.2M
Fundamentals ratios updated end of day